| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corvus Pharmaceuticals, Inc. (CRVS) has 8 insiders with recent SEC Form 4 filings, including 20 buys and 0 sells. CRVS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.34M | $99.35M | - | |
| CEO | 1.00M | $11.91M | - | |
| Other | 400.0K | $4.76M | - | |
| CFO | 400.0K | $4.76M | - | |
| Other | 100.0K | $1.19M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2019 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 657,344 | $3.72 | $2,444,065.11 | +3.5% | |
| Jun 14, 2019 | Miller Richard A Md64 | President And CEO | Buy | 12,000 | $3.41 | $40,873.80 | +0.5% | |
| Jun 11, 2019 | Miller Richard A Md64 | President And CEO | Buy | 15,212 | $3.49 | $53,038.65 | +0.7% | |
| Jun 7, 2019 | Lea Leiv | Chief Financial Officer | Buy | 25,500 | $3.49 | $88,980.00 | +39.3% | |
| Dec 27, 2018 | Miller Richard A Md64 | President And CEO | Buy | 20,000 | $3.29 | $65,884.00 | +1.8% | |
| Dec 21, 2018 | Lea Leiv | Chief Financial Officer | Buy | 24,700 | $4.15 | $102,408.67 | New | |
| Dec 20, 2018 | Miller Richard A Md64 | President And CEO | Buy | 10,000 | $4.40 | $43,950.00 | +0.5% | |
| Dec 6, 2018 | Miller Richard A Md64 | President And CEO | Buy | 5,000 | $5.99 | $29,934.00 | +0.4% | |
| Dec 4, 2018 | Miller Richard A Md64 | President And CEO | Buy | 1,502 | $5.95 | $8,936.90 | +0.1% | |
| Mar 12, 2018 | Gould Terry P | Director, 10% Owner | Buy | 588,235 | $8.50 | $4,999,997.50 | New |